

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.66311075 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.66311075 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.42937277 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.42937277 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.96538841 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.35123048 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.35123048 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.35123048 |
| 9 | epoxygenase P450 pathway (GO:0019373) | 6.13541608 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.09820402 |
| 11 | kynurenine metabolic process (GO:0070189) | 6.01388455 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.99316188 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.81219158 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.79037945 |
| 15 | * urea cycle (GO:0000050) | 5.59483218 |
| 16 | * urea metabolic process (GO:0019627) | 5.59483218 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.43834803 |
| 18 | serine family amino acid catabolic process (GO:0009071) | 5.38774562 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.34189352 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.33982457 |
| 21 | cysteine metabolic process (GO:0006534) | 5.24576349 |
| 22 | omega-hydroxylase P450 pathway (GO:0097267) | 5.19633989 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.17485740 |
| 24 | protein carboxylation (GO:0018214) | 5.16225917 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.16225917 |
| 26 | aromatic amino acid family metabolic process (GO:0009072) | 5.12556478 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 5.12417414 |
| 28 | * nitrogen cycle metabolic process (GO:0071941) | 5.11620864 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.07213259 |
| 30 | regulation of protein activation cascade (GO:2000257) | 5.01473302 |
| 31 | tyrosine metabolic process (GO:0006570) | 4.95809744 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 4.90368679 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.89646998 |
| 34 | bile acid metabolic process (GO:0008206) | 4.89156871 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.88383092 |
| 36 | regulation of plasminogen activation (GO:0010755) | 4.84520113 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.74872095 |
| 38 | reverse cholesterol transport (GO:0043691) | 4.71186646 |
| 39 | * alpha-amino acid catabolic process (GO:1901606) | 4.69666552 |
| 40 | regulation of complement activation (GO:0030449) | 4.66775323 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.65788787 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.65788787 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.65788787 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 4.65302261 |
| 45 | drug metabolic process (GO:0017144) | 4.61154792 |
| 46 | glycine metabolic process (GO:0006544) | 4.59544146 |
| 47 | lysine metabolic process (GO:0006553) | 4.56712843 |
| 48 | lysine catabolic process (GO:0006554) | 4.56712843 |
| 49 | phospholipid efflux (GO:0033700) | 4.54597583 |
| 50 | indolalkylamine metabolic process (GO:0006586) | 4.54043807 |
| 51 | cellular biogenic amine catabolic process (GO:0042402) | 4.49109196 |
| 52 | amine catabolic process (GO:0009310) | 4.49109196 |
| 53 | aldehyde catabolic process (GO:0046185) | 4.48192660 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.43731185 |
| 55 | acylglycerol homeostasis (GO:0055090) | 4.43731185 |
| 56 | ethanol metabolic process (GO:0006067) | 4.43586269 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 4.42616312 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.42616312 |
| 59 | coenzyme catabolic process (GO:0009109) | 4.36456929 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 4.35999889 |
| 61 | serine family amino acid metabolic process (GO:0009069) | 4.33964057 |
| 62 | * cellular amino acid catabolic process (GO:0009063) | 4.31819869 |
| 63 | drug catabolic process (GO:0042737) | 4.27995843 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 4.22270132 |
| 65 | bile acid and bile salt transport (GO:0015721) | 4.18997367 |
| 66 | benzene-containing compound metabolic process (GO:0042537) | 4.17418300 |
| 67 | cellular glucuronidation (GO:0052695) | 4.16083742 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.14949734 |
| 69 | cellular modified amino acid catabolic process (GO:0042219) | 4.12118570 |
| 70 | glutamate metabolic process (GO:0006536) | 4.09419179 |
| 71 | serine family amino acid biosynthetic process (GO:0009070) | 4.09243290 |
| 72 | negative regulation of hemostasis (GO:1900047) | 4.08526290 |
| 73 | negative regulation of blood coagulation (GO:0030195) | 4.08526290 |
| 74 | cholesterol efflux (GO:0033344) | 4.06490565 |
| 75 | * arginine metabolic process (GO:0006525) | 4.05536293 |
| 76 | phenylpropanoid metabolic process (GO:0009698) | 3.97917887 |
| 77 | exogenous drug catabolic process (GO:0042738) | 3.96517679 |
| 78 | fibrinolysis (GO:0042730) | 3.93448512 |
| 79 | NAD biosynthetic process (GO:0009435) | 3.91082750 |
| 80 | cofactor catabolic process (GO:0051187) | 3.89825639 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 3.89703190 |
| 82 | low-density lipoprotein particle remodeling (GO:0034374) | 3.89379467 |
| 83 | glucuronate metabolic process (GO:0019585) | 3.87079946 |
| 84 | uronic acid metabolic process (GO:0006063) | 3.87079946 |
| 85 | blood coagulation, intrinsic pathway (GO:0007597) | 3.86460594 |
| 86 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.85903671 |
| 87 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.85903671 |
| 88 | ethanol oxidation (GO:0006069) | 3.84670615 |
| 89 | negative regulation of coagulation (GO:0050819) | 3.83224832 |
| 90 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.79206826 |
| 91 | * organic acid catabolic process (GO:0016054) | 3.78639219 |
| 92 | * carboxylic acid catabolic process (GO:0046395) | 3.78639219 |
| 93 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.75275994 |
| 94 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.75275994 |
| 95 | proline metabolic process (GO:0006560) | 3.71227173 |
| 96 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.69431053 |
| 97 | negative regulation of lipase activity (GO:0060192) | 3.67247289 |
| 98 | negative regulation of wound healing (GO:0061045) | 3.63368238 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.62216569 |
| 100 | ketone body metabolic process (GO:1902224) | 3.59766077 |
| 101 | acute-phase response (GO:0006953) | 3.59588151 |
| 102 | protein activation cascade (GO:0072376) | 3.59072534 |
| 103 | positive regulation of lipid catabolic process (GO:0050996) | 3.58856537 |
| 104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.58855565 |
| 105 | sterol homeostasis (GO:0055092) | 3.56043118 |
| 106 | flavonoid metabolic process (GO:0009812) | 3.55656275 |
| 107 | complement activation, classical pathway (GO:0006958) | 3.55461208 |
| 108 | regulation of bile acid biosynthetic process (GO:0070857) | 3.55096720 |
| 109 | urate metabolic process (GO:0046415) | 3.55012695 |
| 110 | plasma lipoprotein particle organization (GO:0071827) | 3.53881720 |
| 111 | acetyl-CoA metabolic process (GO:0006084) | 3.53665737 |
| 112 | complement activation (GO:0006956) | 3.52466941 |
| 113 | intestinal cholesterol absorption (GO:0030299) | 3.50883987 |
| 114 | regulation of humoral immune response (GO:0002920) | 3.50076926 |
| 115 | oxidative demethylation (GO:0070989) | 3.42314762 |
| 116 | positive regulation of blood coagulation (GO:0030194) | 3.41923702 |
| 117 | positive regulation of hemostasis (GO:1900048) | 3.41923702 |
| 118 | protein-lipid complex assembly (GO:0065005) | 3.38804454 |
| 119 | regulation of apoptotic cell clearance (GO:2000425) | 3.35378468 |
| 120 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.27181174 |
| 121 | primary alcohol catabolic process (GO:0034310) | 3.26176555 |
| 122 | protein-lipid complex subunit organization (GO:0071825) | 3.25074899 |
| 123 | positive regulation of coagulation (GO:0050820) | 3.23883614 |
| 124 | alkaloid metabolic process (GO:0009820) | 3.21361678 |
| 125 | negative regulation of protein activation cascade (GO:2000258) | 3.20985098 |
| 126 | NADH metabolic process (GO:0006734) | 3.19411375 |
| 127 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.18494227 |
| 128 | hormone catabolic process (GO:0042447) | 3.16004048 |
| 129 | lipoprotein metabolic process (GO:0042157) | 3.15372664 |
| 130 | intestinal absorption (GO:0050892) | 3.14809922 |
| 131 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.10996359 |
| 132 | acute inflammatory response (GO:0002526) | 3.06852541 |
| 133 | polyketide metabolic process (GO:0030638) | 3.03985903 |
| 134 | doxorubicin metabolic process (GO:0044598) | 3.03985903 |
| 135 | daunorubicin metabolic process (GO:0044597) | 3.03985903 |
| 136 | regulation of cholesterol metabolic process (GO:0090181) | 3.03391487 |
| 137 | oxaloacetate metabolic process (GO:0006107) | 3.02278133 |
| 138 | cytolysis (GO:0019835) | 2.99764043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.28781265 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.18172363 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.10050025 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.24771791 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.40283718 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.27972270 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.84412144 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.23024047 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.73840971 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.54981476 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.38185458 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.18612833 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07452984 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8882758 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90544298 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.82475772 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.80208976 |
| 18 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.75995279 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56543868 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.53830600 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49875188 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.49734501 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45858205 |
| 24 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.43548918 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.40522983 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.40249264 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39712621 |
| 28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.33254357 |
| 29 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.32287396 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31784939 |
| 31 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.31637700 |
| 32 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.31260932 |
| 33 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27735017 |
| 34 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27290763 |
| 35 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.25931327 |
| 36 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21296102 |
| 37 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21279911 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.21198804 |
| 39 | P68_20966046_ChIP-Seq_HELA_Human | 1.21025093 |
| 40 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.20969380 |
| 41 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20362270 |
| 42 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19903980 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.11923802 |
| 44 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09716222 |
| 45 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07435971 |
| 46 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07058353 |
| 47 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06744211 |
| 48 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04504732 |
| 49 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.04334902 |
| 50 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04110874 |
| 51 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01717332 |
| 52 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.01575136 |
| 53 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01408187 |
| 54 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00503962 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00301726 |
| 56 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98234121 |
| 57 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97442517 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96290196 |
| 59 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95926276 |
| 60 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95019364 |
| 61 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94614821 |
| 62 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94525768 |
| 63 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.94400133 |
| 64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93272663 |
| 65 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.93111471 |
| 66 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.92870464 |
| 67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92616994 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92311528 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91849018 |
| 70 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91546076 |
| 71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90780285 |
| 72 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90603595 |
| 73 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89581160 |
| 74 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.89224281 |
| 75 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88732475 |
| 76 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88615517 |
| 77 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88393648 |
| 78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.87312980 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87171405 |
| 80 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87010549 |
| 81 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83333839 |
| 82 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80999526 |
| 83 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78527936 |
| 84 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.76321130 |
| 85 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76044319 |
| 86 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74340599 |
| 87 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72980427 |
| 88 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72640729 |
| 89 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72626756 |
| 90 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.71394970 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69707396 |
| 92 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66751503 |
| 93 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.66529488 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.66469053 |
| 95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.65709116 |
| 96 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.64069598 |
| 97 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.63448692 |
| 98 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.63092056 |
| 99 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.60890954 |
| 100 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.58794080 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.58633360 |
| 102 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58452498 |
| 103 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.57629544 |
| 104 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56814005 |
| 105 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.55491203 |
| 106 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54965789 |
| 107 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.54441933 |
| 108 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.53996107 |
| 109 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.53279974 |
| 110 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.50683946 |
| 111 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.50596323 |
| 112 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.50470708 |
| 113 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.50401631 |
| 114 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.50184262 |
| 115 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.49918363 |
| 116 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49863213 |
| 117 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.49394991 |
| 118 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.48986006 |
| 119 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.48384664 |
| 120 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47714149 |
| 121 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47284741 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.46735936 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.46735936 |
| 124 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.46692578 |
| 125 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.46488179 |
| 126 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46317249 |
| 127 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.45806758 |
| 128 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45752880 |
| 129 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45644073 |
| 130 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.45042969 |
| 131 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.44972417 |
| 132 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.44578561 |
| 133 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.43982953 |
| 134 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.43654478 |
| 135 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.43179727 |
| 136 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.41233539 |
| 137 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.40876685 |
| 138 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.40511144 |
| 139 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.40294844 |
| 140 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.39583907 |
| 141 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.38919681 |
| 142 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.38416708 |
| 143 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.38288388 |
| 144 | CBP_21632823_ChIP-Seq_H3396_Human | 0.38232398 |
| 145 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.38154634 |
| 146 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.37343852 |
| 147 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.36951463 |
| 148 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.36742396 |
| 149 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.36697902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.12354131 |
| 2 | MP0005360_urolithiasis | 7.41069836 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.25471021 |
| 4 | MP0005365_abnormal_bile_salt | 5.99002906 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.95461179 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.16866387 |
| 7 | MP0003252_abnormal_bile_duct | 3.73825344 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.40864900 |
| 9 | MP0009840_abnormal_foam_cell | 3.23188480 |
| 10 | MP0005083_abnormal_biliary_tract | 2.94604135 |
| 11 | MP0003195_calcinosis | 2.90122171 |
| 12 | * MP0005332_abnormal_amino_acid | 2.89452038 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.44861519 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.44331391 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.27239390 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.25973332 |
| 17 | MP0000609_abnormal_liver_physiology | 2.10257633 |
| 18 | MP0003868_abnormal_feces_composition | 2.04012925 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.97075062 |
| 20 | MP0001764_abnormal_homeostasis | 1.93215851 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.89598550 |
| 22 | MP0009697_abnormal_copulation | 1.64851572 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57576787 |
| 24 | MP0003186_abnormal_redox_activity | 1.54006392 |
| 25 | MP0003011_delayed_dark_adaptation | 1.51892959 |
| 26 | MP0005451_abnormal_body_composition | 1.51007089 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.46621802 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.42295558 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.39539662 |
| 30 | MP0009764_decreased_sensitivity_to | 1.27336490 |
| 31 | MP0000598_abnormal_liver_morphology | 1.21455799 |
| 32 | MP0008260_abnormal_autophagy | 1.18639564 |
| 33 | MP0005023_abnormal_wound_healing | 1.15128446 |
| 34 | MP0004264_abnormal_extraembryonic_tissu | 1.12727505 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.11783800 |
| 36 | MP0005636_abnormal_mineral_homeostasis | 1.09661069 |
| 37 | MP0003303_peritoneal_inflammation | 1.09254528 |
| 38 | MP0008438_abnormal_cutaneous_collagen | 1.08738608 |
| 39 | MP0008469_abnormal_protein_level | 1.08649923 |
| 40 | MP0005647_abnormal_sex_gland | 1.08611484 |
| 41 | MP0002876_abnormal_thyroid_physiology | 1.07805735 |
| 42 | MP0005408_hypopigmentation | 1.07134871 |
| 43 | MP0009763_increased_sensitivity_to | 1.04227853 |
| 44 | MP0003566_abnormal_cell_adhesion | 1.01996862 |
| 45 | MP0000858_altered_metastatic_potential | 1.01190503 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 0.99475074 |
| 47 | MP0002254_reproductive_system_inflammat | 0.92236280 |
| 48 | * MP0009642_abnormal_blood_homeostasis | 0.91846378 |
| 49 | MP0003172_abnormal_lysosome_physiology | 0.91023674 |
| 50 | MP0005670_abnormal_white_adipose | 0.88605295 |
| 51 | MP0004272_abnormal_basement_membrane | 0.87137058 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 0.87098725 |
| 53 | MP0001849_ear_inflammation | 0.86643396 |
| 54 | MP0005376_homeostasis/metabolism_phenot | 0.84018582 |
| 55 | MP0000604_amyloidosis | 0.83962182 |
| 56 | MP0001756_abnormal_urination | 0.82340669 |
| 57 | MP0009765_abnormal_xenobiotic_induced | 0.81974141 |
| 58 | MP0003724_increased_susceptibility_to | 0.81880722 |
| 59 | MP0002822_catalepsy | 0.78082617 |
| 60 | MP0001533_abnormal_skeleton_physiology | 0.76686635 |
| 61 | MP0003436_decreased_susceptibility_to | 0.75378107 |
| 62 | MP0000678_abnormal_parathyroid_gland | 0.75144090 |
| 63 | MP0005220_abnormal_exocrine_pancreas | 0.74975894 |
| 64 | MP0005464_abnormal_platelet_physiology | 0.74785045 |
| 65 | MP0000003_abnormal_adipose_tissue | 0.74690041 |
| 66 | MP0002078_abnormal_glucose_homeostasis | 0.74276813 |
| 67 | MP0003183_abnormal_peptide_metabolism | 0.73279017 |
| 68 | MP0000013_abnormal_adipose_tissue | 0.72756394 |
| 69 | MP0004947_skin_inflammation | 0.72663826 |
| 70 | MP0010368_abnormal_lymphatic_system | 0.70971537 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 0.70420496 |
| 72 | MP0003329_amyloid_beta_deposits | 0.70306907 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 0.68483972 |
| 74 | MP0001663_abnormal_digestive_system | 0.67351958 |
| 75 | MP0005334_abnormal_fat_pad | 0.67089138 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 0.67014212 |
| 77 | MP0005257_abnormal_intraocular_pressure | 0.66166077 |
| 78 | MP0002796_impaired_skin_barrier | 0.65380907 |
| 79 | MP0003879_abnormal_hair_cell | 0.64758386 |
| 80 | MP0005266_abnormal_metabolism | 0.63602556 |
| 81 | MP0000467_abnormal_esophagus_morphology | 0.63160228 |
| 82 | MP0002136_abnormal_kidney_physiology | 0.62751058 |
| 83 | MP0003718_maternal_effect | 0.62665205 |
| 84 | MP0004381_abnormal_hair_follicle | 0.62581386 |
| 85 | MP0005535_abnormal_body_temperature | 0.62309360 |
| 86 | MP0001873_stomach_inflammation | 0.60729718 |
| 87 | MP0001661_extended_life_span | 0.60580536 |
| 88 | MP0005666_abnormal_adipose_tissue | 0.59561436 |
| 89 | MP0002971_abnormal_brown_adipose | 0.59356933 |
| 90 | MP0005165_increased_susceptibility_to | 0.59300393 |
| 91 | MP0005375_adipose_tissue_phenotype | 0.59082976 |
| 92 | MP0005501_abnormal_skin_physiology | 0.58181054 |
| 93 | MP0000639_abnormal_adrenal_gland | 0.57571197 |
| 94 | MP0001915_intracranial_hemorrhage | 0.56443513 |
| 95 | MP0002060_abnormal_skin_morphology | 0.55099219 |
| 96 | MP0005381_digestive/alimentary_phenotyp | 0.55017746 |
| 97 | MP0000477_abnormal_intestine_morphology | 0.54163742 |
| 98 | MP0005395_other_phenotype | 0.53696594 |
| 99 | MP0002148_abnormal_hypersensitivity_rea | 0.53200066 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.53030693 |
| 101 | MP0009053_abnormal_anal_canal | 0.52741546 |
| 102 | MP0003866_abnormal_defecation | 0.52542710 |
| 103 | MP0009379_abnormal_foot_pigmentation | 0.52066930 |
| 104 | MP0009785_altered_susceptibility_to | 0.51221909 |
| 105 | MP0001853_heart_inflammation | 0.50800415 |
| 106 | MP0006035_abnormal_mitochondrial_morpho | 0.50294566 |
| 107 | MP0001845_abnormal_inflammatory_respons | 0.49968548 |
| 108 | MP0008873_increased_physiological_sensi | 0.49691828 |
| 109 | MP0002928_abnormal_bile_duct | 0.49659217 |
| 110 | MP0005448_abnormal_energy_balance | 0.48031557 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.47674844 |
| 112 | MP0004130_abnormal_muscle_cell | 0.47085882 |
| 113 | MP0005058_abnormal_lysosome_morphology | 0.47081560 |
| 114 | MP0006082_CNS_inflammation | 0.44767028 |
| 115 | MP0002132_abnormal_respiratory_system | 0.44052676 |
| 116 | MP0008874_decreased_physiological_sensi | 0.41967358 |
| 117 | MP0003075_altered_response_to | 0.40871708 |
| 118 | MP0003953_abnormal_hormone_level | 0.40546485 |
| 119 | MP0005075_abnormal_melanosome_morpholog | 0.40465918 |
| 120 | MP0008872_abnormal_physiological_respon | 0.39660264 |
| 121 | MP0005025_abnormal_response_to | 0.39603146 |
| 122 | MP0000249_abnormal_blood_vessel | 0.38973052 |
| 123 | MP0001835_abnormal_antigen_presentation | 0.37472673 |
| 124 | MP0002419_abnormal_innate_immunity | 0.36518080 |
| 125 | MP0004883_abnormal_blood_vessel | 0.36458433 |
| 126 | MP0005166_decreased_susceptibility_to | 0.36332548 |
| 127 | MP0003690_abnormal_glial_cell | 0.36216322 |
| 128 | MP0000538_abnormal_urinary_bladder | 0.34830030 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.34561827 |
| 130 | MP0002168_other_aberrant_phenotype | 0.33098770 |
| 131 | MP0002135_abnormal_kidney_morphology | 0.32920090 |
| 132 | MP0009115_abnormal_fat_cell | 0.31504848 |
| 133 | MP0002970_abnormal_white_adipose | 0.29503186 |
| 134 | MP0001881_abnormal_mammary_gland | 0.29307139 |
| 135 | MP0000685_abnormal_immune_system | 0.28967769 |
| 136 | MP0000579_abnormal_nail_morphology | 0.27173641 |
| 137 | MP0005164_abnormal_response_to | 0.26685913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.64673361 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.74981385 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.74245247 |
| 4 | * Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.58564503 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.48390554 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.03253914 |
| 7 | Xanthomatosis (HP:0000991) | 6.00034843 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.23899519 |
| 9 | Complement deficiency (HP:0004431) | 4.98959317 |
| 10 | Joint hemorrhage (HP:0005261) | 4.97961317 |
| 11 | Hyperglycinemia (HP:0002154) | 4.52382522 |
| 12 | Abnormality of methionine metabolism (HP:0010901) | 4.51776721 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.43908551 |
| 14 | * Hyperammonemia (HP:0001987) | 4.39225876 |
| 15 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.38235422 |
| 16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.33917483 |
| 17 | Epidermoid cyst (HP:0200040) | 4.25826760 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.25567278 |
| 19 | Hyperglycinuria (HP:0003108) | 4.19350778 |
| 20 | Ketosis (HP:0001946) | 4.12791169 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.05667475 |
| 22 | * Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.03187612 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.95523720 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.95523720 |
| 25 | Fat malabsorption (HP:0002630) | 3.88224779 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.86416822 |
| 27 | * Abnormality of pyrimidine metabolism (HP:0004353) | 3.76728683 |
| 28 | Abnormality of complement system (HP:0005339) | 3.75646713 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.65814508 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.60389550 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.59307782 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.45606702 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.40424142 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.37537386 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.33299124 |
| 36 | * Abnormality of nucleobase metabolism (HP:0010932) | 3.08142222 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.04381266 |
| 38 | Steatorrhea (HP:0002570) | 2.99954955 |
| 39 | Hepatocellular carcinoma (HP:0001402) | 2.92186408 |
| 40 | * Abnormality of serum amino acid levels (HP:0003112) | 2.91869855 |
| 41 | Spontaneous abortion (HP:0005268) | 2.84655875 |
| 42 | Systemic lupus erythematosus (HP:0002725) | 2.83450119 |
| 43 | Metabolic acidosis (HP:0001942) | 2.82898727 |
| 44 | Ketoacidosis (HP:0001993) | 2.82359848 |
| 45 | Purpura (HP:0000979) | 2.81164290 |
| 46 | Myocardial infarction (HP:0001658) | 2.79267688 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 2.76966558 |
| 48 | * Lethargy (HP:0001254) | 2.74201693 |
| 49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.72840901 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.72840901 |
| 51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.66564870 |
| 52 | Vascular calcification (HP:0004934) | 2.61099824 |
| 53 | Glomerulonephritis (HP:0000099) | 2.60434702 |
| 54 | Gout (HP:0001997) | 2.60117309 |
| 55 | Skin nodule (HP:0200036) | 2.54887404 |
| 56 | Abnormality of the Achilles tendon (HP:0005109) | 2.53511109 |
| 57 | Increased serum ferritin (HP:0003281) | 2.51063157 |
| 58 | Hypochromic microcytic anemia (HP:0004840) | 2.47068235 |
| 59 | Generalized aminoaciduria (HP:0002909) | 2.40722041 |
| 60 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.37889423 |
| 61 | Mucopolysacchariduria (HP:0008155) | 2.37889423 |
| 62 | Spastic diplegia (HP:0001264) | 2.37035654 |
| 63 | Menorrhagia (HP:0000132) | 2.35145979 |
| 64 | * Cerebral edema (HP:0002181) | 2.33836346 |
| 65 | Late onset (HP:0003584) | 2.33185272 |
| 66 | Hypoglycemic seizures (HP:0002173) | 2.31630000 |
| 67 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.30797678 |
| 68 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.30797678 |
| 69 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.30797678 |
| 70 | Pancreatitis (HP:0001733) | 2.30520092 |
| 71 | Amyloidosis (HP:0011034) | 2.30451700 |
| 72 | * Irritability (HP:0000737) | 2.30128515 |
| 73 | Gingival bleeding (HP:0000225) | 2.29794300 |
| 74 | Malnutrition (HP:0004395) | 2.27597185 |
| 75 | Mitral stenosis (HP:0001718) | 2.26309901 |
| 76 | Cardiovascular calcification (HP:0011915) | 2.26206927 |
| 77 | Elevated alkaline phosphatase (HP:0003155) | 2.25584374 |
| 78 | Enlarged kidneys (HP:0000105) | 2.22594979 |
| 79 | Acanthocytosis (HP:0001927) | 2.21299071 |
| 80 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.21265297 |
| 81 | Abnormal gallbladder morphology (HP:0012437) | 2.20458614 |
| 82 | Thrombophlebitis (HP:0004418) | 2.19801189 |
| 83 | Dysostosis multiplex (HP:0000943) | 2.18337990 |
| 84 | Opisthotonus (HP:0002179) | 2.17986922 |
| 85 | Vertebral compression fractures (HP:0002953) | 2.17958970 |
| 86 | Cholelithiasis (HP:0001081) | 2.15313008 |
| 87 | Abnormal gallbladder physiology (HP:0012438) | 2.14767179 |
| 88 | Cholecystitis (HP:0001082) | 2.14767179 |
| 89 | * Vomiting (HP:0002013) | 2.14028868 |
| 90 | Brushfield spots (HP:0001088) | 2.13195429 |
| 91 | J-shaped sella turcica (HP:0002680) | 2.10991623 |
| 92 | Esophageal varix (HP:0002040) | 2.08142257 |
| 93 | Vacuolated lymphocytes (HP:0001922) | 2.06270212 |
| 94 | * Neonatal onset (HP:0003623) | 2.05794565 |
| 95 | Proximal tubulopathy (HP:0000114) | 2.01587511 |
| 96 | Abnormality of urine glucose concentration (HP:0011016) | 2.00739380 |
| 97 | Glycosuria (HP:0003076) | 2.00739380 |
| 98 | Sensorimotor neuropathy (HP:0007141) | 1.99874337 |
| 99 | Flat acetabular roof (HP:0003180) | 1.99554145 |
| 100 | Renal cortical cysts (HP:0000803) | 1.98364730 |
| 101 | Elevated hepatic transaminases (HP:0002910) | 1.97802386 |
| 102 | Abnormality of proline metabolism (HP:0010907) | 1.97799184 |
| 103 | Hydroxyprolinuria (HP:0003080) | 1.97799184 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 1.96318446 |
| 105 | Cerebral palsy (HP:0100021) | 1.95704425 |
| 106 | Rickets (HP:0002748) | 1.93077218 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92616802 |
| 108 | Abnormality of carpal bone ossification (HP:0006257) | 1.89017966 |
| 109 | Reticulocytosis (HP:0001923) | 1.87971552 |
| 110 | Hypophosphatemic rickets (HP:0004912) | 1.87441426 |
| 111 | Impaired platelet aggregation (HP:0003540) | 1.86985255 |
| 112 | Abnormal platelet function (HP:0011869) | 1.86985255 |
| 113 | Nephritis (HP:0000123) | 1.85957249 |
| 114 | Hemorrhage of the eye (HP:0011885) | 1.85601243 |
| 115 | * Alkalosis (HP:0001948) | 1.85591017 |
| 116 | Achilles tendon contracture (HP:0001771) | 1.85485472 |
| 117 | Hypertriglyceridemia (HP:0002155) | 1.85282549 |
| 118 | Abdominal distention (HP:0003270) | 1.85173977 |
| 119 | Abnormality of the gallbladder (HP:0005264) | 1.85007620 |
| 120 | Nausea (HP:0002018) | 1.84399563 |
| 121 | Poikilocytosis (HP:0004447) | 1.82463408 |
| 122 | Epistaxis (HP:0000421) | 1.82025729 |
| 123 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81963875 |
| 124 | Cervical subluxation (HP:0003308) | 1.79475688 |
| 125 | Reduced antithrombin III activity (HP:0001976) | 1.79361609 |
| 126 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.79017208 |
| 127 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.79017208 |
| 128 | Abnormality of glycolipid metabolism (HP:0010969) | 1.79017208 |
| 129 | Ileus (HP:0002595) | 1.77836666 |
| 130 | Increased serum pyruvate (HP:0003542) | 1.77752887 |
| 131 | Prolonged neonatal jaundice (HP:0006579) | 1.76511422 |
| 132 | Hypophosphatemia (HP:0002148) | 1.73156152 |
| 133 | Abnormality of glycolysis (HP:0004366) | 1.73094548 |
| 134 | Abnormal tarsal ossification (HP:0008369) | 1.71888497 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.22042947 |
| 2 | FGFR4 | 4.11086720 |
| 3 | EPHA2 | 4.05084392 |
| 4 | ERN1 | 4.04827442 |
| 5 | SIK1 | 3.53418678 |
| 6 | TAOK3 | 2.98331603 |
| 7 | FLT3 | 2.68894973 |
| 8 | INSRR | 2.68764428 |
| 9 | ERBB4 | 2.48826035 |
| 10 | RIPK1 | 2.32433657 |
| 11 | TESK2 | 2.21693515 |
| 12 | TESK1 | 2.15949427 |
| 13 | LMTK2 | 2.11743661 |
| 14 | IRAK3 | 2.11634237 |
| 15 | MAPK11 | 2.04874718 |
| 16 | SMG1 | 1.84999648 |
| 17 | NME2 | 1.84995764 |
| 18 | MST1R | 1.81975642 |
| 19 | TYK2 | 1.81937977 |
| 20 | MAP3K14 | 1.77999678 |
| 21 | PRPF4B | 1.75985182 |
| 22 | MAP3K12 | 1.69686522 |
| 23 | NEK9 | 1.68975257 |
| 24 | MAP2K4 | 1.67571832 |
| 25 | PIK3CG | 1.67252971 |
| 26 | TBK1 | 1.63583740 |
| 27 | PAK4 | 1.59858429 |
| 28 | PKN2 | 1.52120272 |
| 29 | ABL2 | 1.50925573 |
| 30 | PDK2 | 1.46069386 |
| 31 | MAP2K3 | 1.40138430 |
| 32 | KDR | 1.40085329 |
| 33 | IKBKE | 1.23824324 |
| 34 | GRK6 | 1.19916902 |
| 35 | MAPKAPK3 | 1.19687793 |
| 36 | MAP3K11 | 1.18855733 |
| 37 | JAK2 | 1.18290058 |
| 38 | STK16 | 1.12205117 |
| 39 | PINK1 | 1.10975906 |
| 40 | PDPK1 | 1.05181225 |
| 41 | MAPK4 | 1.04228952 |
| 42 | ARAF | 1.01676745 |
| 43 | TIE1 | 1.01421781 |
| 44 | MAP3K1 | 1.00233224 |
| 45 | ICK | 0.99539949 |
| 46 | SCYL2 | 0.99047580 |
| 47 | EPHA3 | 0.98927413 |
| 48 | STK38L | 0.98568664 |
| 49 | PRKAA2 | 0.97887388 |
| 50 | MAP2K6 | 0.94453470 |
| 51 | PTK6 | 0.92379454 |
| 52 | DAPK2 | 0.91686388 |
| 53 | JAK1 | 0.90808398 |
| 54 | ERBB2 | 0.90799775 |
| 55 | IRAK4 | 0.90401650 |
| 56 | ZAP70 | 0.89455343 |
| 57 | BLK | 0.88325408 |
| 58 | PDGFRA | 0.87886576 |
| 59 | TAOK2 | 0.87839814 |
| 60 | TLK1 | 0.86562254 |
| 61 | CDC42BPA | 0.85759583 |
| 62 | DDR2 | 0.85030585 |
| 63 | FRK | 0.83936775 |
| 64 | PRKD2 | 0.83548719 |
| 65 | MAP3K7 | 0.83065725 |
| 66 | LIMK1 | 0.82202486 |
| 67 | PIK3CA | 0.82156200 |
| 68 | IKBKB | 0.82041698 |
| 69 | CSK | 0.81287726 |
| 70 | NLK | 0.80949107 |
| 71 | IRAK1 | 0.80652204 |
| 72 | MAP3K3 | 0.80525250 |
| 73 | EIF2AK3 | 0.79421877 |
| 74 | MAPK12 | 0.78584615 |
| 75 | DYRK1B | 0.77554979 |
| 76 | KIT | 0.76374502 |
| 77 | TGFBR2 | 0.74036037 |
| 78 | ILK | 0.70879010 |
| 79 | TAOK1 | 0.70747791 |
| 80 | PBK | 0.70252411 |
| 81 | TRIB3 | 0.69804846 |
| 82 | MAPK15 | 0.67236624 |
| 83 | MAP4K1 | 0.67128814 |
| 84 | EPHB2 | 0.67088431 |
| 85 | PRKCZ | 0.67035752 |
| 86 | KSR2 | 0.66771941 |
| 87 | IRAK2 | 0.66653148 |
| 88 | EEF2K | 0.63212797 |
| 89 | BTK | 0.62338585 |
| 90 | CSF1R | 0.61972274 |
| 91 | JAK3 | 0.61058265 |
| 92 | PRKACG | 0.60770551 |
| 93 | LATS1 | 0.58550647 |
| 94 | BMX | 0.57981209 |
| 95 | TEC | 0.57853422 |
| 96 | MAP3K6 | 0.57671694 |
| 97 | SGK2 | 0.57315844 |
| 98 | GSK3A | 0.57122333 |
| 99 | MAP3K10 | 0.56541096 |
| 100 | CSNK1G1 | 0.55788892 |
| 101 | CAMK2G | 0.55440003 |
| 102 | TXK | 0.54456691 |
| 103 | CAMK4 | 0.53914856 |
| 104 | MAP3K8 | 0.53614073 |
| 105 | DAPK3 | 0.53545582 |
| 106 | PRKCI | 0.52668740 |
| 107 | PDK1 | 0.52585196 |
| 108 | MET | 0.52443390 |
| 109 | CDK6 | 0.51335314 |
| 110 | SGK3 | 0.50951836 |
| 111 | EPHB1 | 0.50785401 |
| 112 | RPS6KB2 | 0.50501225 |
| 113 | GRK1 | 0.49028705 |
| 114 | FER | 0.48919351 |
| 115 | LRRK2 | 0.47485086 |
| 116 | CHUK | 0.46714278 |
| 117 | MAP3K2 | 0.46130676 |
| 118 | IGF1R | 0.44005706 |
| 119 | PTK2 | 0.42257750 |
| 120 | LYN | 0.40900432 |
| 121 | DAPK1 | 0.39040570 |
| 122 | PRKAA1 | 0.38993210 |
| 123 | PIM1 | 0.37698055 |
| 124 | MAPKAPK2 | 0.37474023 |
| 125 | FGFR3 | 0.35362326 |
| 126 | CDK4 | 0.34354416 |
| 127 | MST4 | 0.34301867 |
| 128 | NME1 | 0.34151989 |
| 129 | EIF2AK2 | 0.34143720 |
| 130 | EIF2AK1 | 0.33858856 |
| 131 | SRC | 0.33599483 |
| 132 | RET | 0.32922823 |
| 133 | MAP3K5 | 0.31943831 |
| 134 | NTRK1 | 0.30771375 |
| 135 | MAP3K13 | 0.30416470 |
| 136 | MAP2K1 | 0.30318543 |
| 137 | PIM2 | 0.30204829 |
| 138 | MATK | 0.30063639 |
| 139 | MTOR | 0.29927233 |
| 140 | PRKCQ | 0.29681293 |
| 141 | AKT2 | 0.28681489 |
| 142 | MAP2K2 | 0.28488030 |
| 143 | AKT3 | 0.28429289 |
| 144 | SGK223 | 0.28210279 |
| 145 | SGK494 | 0.28210279 |
| 146 | MYLK | 0.28008838 |
| 147 | SYK | 0.27823624 |
| 148 | PRKG2 | 0.27646347 |
| 149 | FGR | 0.24316752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.45172123 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.44288078 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.35893321 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.17914449 |
| 5 | * Arginine biosynthesis_Homo sapiens_hsa00220 | 3.00316180 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72190421 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.70151615 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.68418758 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62533569 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.58701500 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.42266727 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.39546490 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35197709 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.16235585 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15786086 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01530908 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.99288423 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96930830 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94411235 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92981255 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.82963544 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.82936551 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78767115 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.76688943 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72748485 |
| 26 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.71675324 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.69635620 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68343227 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64969315 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.63962677 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.63538507 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62959174 |
| 33 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.54617342 |
| 34 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.52382927 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.51142218 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48479472 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.43199472 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.40607559 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37340053 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.36389334 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.30784473 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29229519 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25656470 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.19567904 |
| 45 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18207631 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17171829 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.16713521 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.13635095 |
| 49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11960678 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11932835 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11323371 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07976110 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.07804904 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07709273 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.06916979 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.00547363 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96294479 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76021173 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74644899 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.72486918 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72472415 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69767122 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67516100 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62360164 |
| 65 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.52845204 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.51914269 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.42904956 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39826989 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38676279 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35583080 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35136935 |
| 72 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31915572 |
| 73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.31272008 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.27001782 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25670196 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.24961915 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21741285 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14721969 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.14652235 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.14272173 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.13992821 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.13954527 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.13107029 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11168257 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07969376 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.05514638 |
| 87 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.05228975 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.00298435 |
| 89 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | -0.2068510 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1991746 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | -0.1984266 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1847923 |
| 93 | Protein export_Homo sapiens_hsa03060 | -0.1818643 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1758244 |
| 95 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1709700 |
| 96 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1674544 |
| 97 | Pertussis_Homo sapiens_hsa05133 | -0.1479481 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | -0.1367559 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1256244 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1234358 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1171625 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1158310 |
| 103 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1080403 |
| 104 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0741023 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0683651 |
| 106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0581925 |
| 107 | Shigellosis_Homo sapiens_hsa05131 | -0.0470239 |
| 108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | -0.0433708 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0288285 |
| 110 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0248237 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | -0.0244059 |
| 112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0088394 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0083697 |
| 114 | Leishmaniasis_Homo sapiens_hsa05140 | -0.0023102 |

